EGX:MPCI Revenue

Memphis Pharmaceuticals & Chemical Industries had revenue of 399.66M EGP in the quarter ending September 30, 2024, with 118.81% growth. This brings the company's revenue in the last twelve months to 1.09B, up 56.42% year-over-year. In the fiscal year ending June 30, 2024, Memphis Pharmaceuticals & Chemical Industries had annual revenue of 871.91M with 31.34% growth.

Revenue (ttm)

1.09B

Revenue Growth

+56.42%

P/S Ratio

0.29

Revenue / Employee

7.56M

Employees

144

Market Cap

1.30B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	871.91M	208.07M	31.34%
Jun 30, 2023	663.83M	112.57M	20.42%
Jun 30, 2022	551.26M	33.15M	6.40%
Jun 30, 2021	518.11M	29.70M	6.08%
Jun 30, 2020	488.41M	125.34M	34.52%
Jun 30, 2019	Pro	Pro	Pro
Jun 30, 2018	Pro	Pro	Pro
Jun 30, 2017	Pro	Pro	Pro
Jun 30, 2016	Pro	Pro	Pro
Jun 30, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Commercial International Bank (Egypt) S.A.E	100.42B
El Sewedy Electric Company	208.20B
Talaat Moustafa Group Holding	37.97B
Eastern Company S.A.E	25.47B
Misr Fertilizer Production Company	5.80B
Ezz Steel Company (S.A.E)	181.34B
Abu Qir Fertilizers and Chemical Industries Co. (S.A.E.)	17.82B
Alexandria Container&Cargo Handling Company	7.49B

Revenue Rankings